The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device?

Cancer Journal

Volumn 8, Issue 6, 2002, Pages 476-483

  Teh, Bin S ^a   McGary, John E ^a   Dong, Lei ^a,b   Mai, Wei Yuan ^a   Carpenter, L Steve ^a   Lu, Hsin H ^a   Chiu, J Kam ^a   Woo, Shiao Y ^a   Grant, Walter H ^a   Butler, E Brian ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Dose escalation; Dosimetric effects; Immobilization; Intensity modulated radiotherapy (IMRT); Prostate cancer; Radiotherapy; Rectal balloon; Rectal dose sparing; Reduced rectal toxicity

Indexed keywords

ARTICLE; BALLOON; BODY POSTURE; BREATHING; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FILM; HISTOGRAM; HUMAN; IMMOBILIZATION; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PATIENT POSITIONING; PHANTOM; PHOTON; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM BALLOON; RECTUM INJURY; SIMULATION; TUMOR VOLUME; BALLOON DILATATION; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOMETRY; RECTUM;

BALLOON DILATATION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMMOBILIZATION; MALE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY, CONFORMAL; RECTUM;

EID: 0036835238     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200211000-00012     Document Type: Article

References (50)

1. Greenlee RT, Hill-Harmon MB, Murray T et al. Cancer statistics. 2001 CA Cancer J Clin 51:15-36.
2. Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1985;15:1299-1305.
3. Pollack A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:1011-1018.
4. Hanks GE, Hanlon AL, Schultheiss TE et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998;41:501-510.
5. Zelefsky MJ, Leibel SA, Guadin PB et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
6. Pollack A, Zagars GK, Smith LG et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000;18:3904-3911.
7. Lawton CA, Won M, Pilepich MV et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991;21:935-939.
8. Smit WG, Helle PA, van Putten WL et al. Late radiation damage in prostate cancer patients treated with high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990;18:23-29.
9. Dearnaley DP, Khoo VS, Norman AR et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 1999;353:267-272.
10. Koper PCM, Stroom JC, Van Putten WL et al. Acute morbidity reduction using 3D-CRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 1999;43:727-734.
11. Woo SY, Sanders M, Grant WH et al. Does the "Peacock" have anything to do with radiation therapy? Int J Radiat Oncol Biol Phys 1994;29:213-214.
12. Purdy JA. Intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 1996;35:845-846.
13. Teh BS, Woo SY, Butler EB. Intensity modulated radiation therapy: a new promising technology in radiation oncology. Oncologist 1999;4:433-442.
14. Ten Haken RK, Forman, JD, Heimburger K et al. Treatment planning issues related to prostatemovement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 1991;20:1317-1324.
15. Crook JM, Raymond Y, Salhani D et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995;37:35-42.
16. Melian E, Mageras GS, Fuks Z et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997;38:73-81.
17. Padhani AR, Khoo VS, Suckling JS et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999;44:525-533.
18. Teh BS, Greco S, Berner B et al. Prostate movement: a function of shift and rotation. J Brachyther Int 2000;16:199-206.
19. Antolak JA, Rosen II, Childress CC et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 1998;42:661-672.
20. Balter JM, Sandler HM, Lam K et al. Measurement of prostate movementover the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 1995;31:113-118.
21. Roeske J, Forman J, Mesina C et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1321-1329.
22. Langen KM, Jones DTL. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001;50:265-278.
23. Lattanzi J, McNeely S, Pinover W et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 1999;43:719-725.
24. Lattanzi J, McNeely S, Hanlon A et al. Daily CT localization for correcting portal errors in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:1079-1086.
25. Balter JM, Lam KL, Sandler HM et al. Automated localization of the prostate at the time of treatment using implanted radio-opaque markers: technical feasibility. Int J Radiat Oncol Biol Phys 1995;33:1281-1286.
26. Vigneault E, Pouliot J, Laverdiere J et al. Electronic portal imaging device detection of radio-opaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 1997;37:205-212.
27. Bergstrom P, Lofroth PO, Widmark A. High precision conformal radiotherapy (HPCRT) of prostate cancer: a new technique for exact positioning of the prostate at the time of treatment. Int J Radiat Oncol Biol Phys 1998;42:305-311.
28. Teh BS, Mai WY, Uhl BM et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose volume analysis. Int J Radiat Oncol Biol Phys 2000;49:705-712.
29. McGary JE, Grant W III. A clinical evaluation of setup errors for a prostate immobilization system. J App Clin Med Phys 2000;1:138-147.
30. D'Amico AV, Manola J, Loffredo M et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys 2001;51:1431-1436.
31. Wachter S, Gerstner N, Dorner D et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100.
32. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
33. Dawson LA, Litzenberg DW, Brock KK et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000;48:319-323.
34. Schultheiss TE, Lee WR, Hunt MA et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3-11.
35. Teshima T, Hanks GE, Hanlon AL et al. Rectal bleeding after conformal 3D treatment of prostate: time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 1997;39:77-83.
36. Michalski JM, Purdy JA, Winter K et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000;46:391-402.
37. Storey MR, Pollack A, Zagars G et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-642.
38. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43:1095-1101.
39. Duschesne GM, Peters LJ.What is the alpha/beta ration for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999;44:747-748.
40. Brenner DJ. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:315-316.
41. King CR, Fowler JF. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys 2001;51:213-214.
42. Fowler J, Chappell R, Ritter M. Is the alpha/beta for prostate tumors low? Int J Radiat Oncol Biol Phys 2001;50:1021-1031.
43. D'Souza WD, Thames HD. Is the alpha/beta ratio for prostate cancer low? Int J Radiat Oncol Biol Phys 2001;51:1-3.
44. Brenner DJ, Martinez AA, Edmundson GK et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio) comparable to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6-13.
45. Lloyd-Davies RW, Collins CD, Swan AV. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation: twenty-two years' experience (1962-1984). Urology 1990:36:107-111.
46. Pollack A, Zagars GK, Starkschall G et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996;34:555-564.
47. Mohab DS, Kupelian PA, Willoughby TR. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int J Radiat Oncol Biol Phys 2000;46:575-580.
48. Chen ME, Johnston DA, Tang K et al. Detailed mapping of prostate carcinoma foci. Cancer 2000;89:1800-1809.
49. Boersma LJ, van den Brink M, Bruce AM et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92.
50. Li XA, Yu C, Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. Med Phys 2000;27:1011-1017.